TipRanks
Chemomab Therapeutics (DE:2QV)
FRANKFURT:2QV

Compare Chemomab Therapeutics (2QV) vs. Competitors

1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Chemomab Therapeutics
€2.94
€8.92M
-1.37
0.00%
1 Buy
0 Hold
0 Sell
Moderate Buy
Tenax Therapeutics
$2.32
$69.98M
-1.23
-75.93%
6 Buy
4 Hold
0 Sell
Moderate Buy
Q32 Bio
$16.32
$248.28M
2.99
157.41%
7 Buy
0 Hold
0 Sell
Strong Buy
Passage Bio
$4.52
$11.87M
-0.33
-57.51%
0 Buy
1 Hold
0 Sell
Hold
CalciMedica
$0.59
$8.67M
-0.18
-92.49%
1 Buy
1 Hold
0 Sell
Moderate Buy
Longeveron
$0.68
$7.91M
-0.24
-71.97%
1 Buy
1 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:2QV
Chemomab Therapeutics
2.94
0.00
0.00%
TENX
Tenax Therapeutics
1.87
-5.54
-74.76%
QTTB
Q32 Bio
8.34
4.39
111.14%
PASG
Passage Bio
3.69
-5.00
-57.54%
CALC
CalciMedica
1.27
-15.03
-92.21%
LGVN
Longeveron
2.48
-5.52
-69.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts